Cilcare

Private

MontpellierHealthcare & Life Scienceshttps://www.cilcare.com/

Last Round

Series A

Dec 4, 2024

Total Funding Raised

$46.84M

Company Overview

Cilcare is a biotechnology company that specializes in auditory sciences, providing research and development services and developing proprietary drug candidates for the treatment of hearing disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

contract research organizationCROauditory researchdrug developmenthearing lossotologypreclinical researchclinical trialsauditory biomarkerstinnitus researchototoxicityauditory analyticsbiotech servicesdigital auditory signaturesneuro-otology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cilcare Comps

Public and private peers based on sector, stage, and business model.

Cilcare comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cilcare Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Dec 4, 2024
Grant	Jun 27, 2024
Pre Seed	Dec 1, 2014
Seed	Jul 1, 2014

View all Funding Rounds

Key People

Founding team and executive leadership

Celia Belline

Chief Executive Officer

Executive Team

Cilcare Investors

Notable investors and investment history

Cilcare investors
Investor	Rounds
Sofilaro	Seed, Series A
Shionogi & Co.	Series A
Créalia Occitanie	Pre Seed, Seed
SPRIM Global Investments	Series A
Occitanie Angels	Pre Seed, Seed
Bpifrance	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 1, 2026
Grew 19% QoQ, from 54 to 64 employees.
Dec 4, 2024
$42M round with participation from Sofilaro and SPRIM Global Investments.

View all signals

Cilcare Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cilcare Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cilcare's valuation, stock price, and market status.

Firmographic Details

HeadquartersMontpellier

Employee Range65

Year Founded2014

Last FundingDec 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.